Publications:

Therapeutic Advances in Oncology.

International Journal Of Molecular Sciences

Liu, Jinsha J; Pandya, Priyanka P; Afshar, Sepideh S

Publication Date: 2021-02-18

Variant appearance in text: ALK: L1169M

PubMed Link: 33670524

Variant Present in the following documents:

• Main text
• ijms-22-02008.pdf

View BVdb publication page

Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.

The Lancet. Oncology

Shaw, Alice T AT; Felip, Enriqueta E; Bauer, Todd M TM; Besse, Benjamin B; Navarro, Alejandro A; Postel-Vinay, Sophie S; Gainor, Justin F JF; Johnson, Melissa M; Dietrich, Jorg J; James, Leonard P LP; Clancy, Jill S JS; Chen, Joseph J; Martini, Jean-François JF; Abbattista, Antonello A; Solomon, Benjamin J BJ

Publication Date: 2017-12

Variant appearance in text: ALK: L1169M

PubMed Link: 29074098

Variant Present in the following documents:

• NIHMS930149-supplement.pdf

View BVdb publication page

Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities.

Oncotarget

Tabbò, Fabrizio F; Pizzi, Marco M; Kyriakides, Peter W PW; Ruggeri, Bruce B; Inghirami, Giorgio G

Publication Date: 2016-05-03

Variant appearance in text: ALK: L1169M

PubMed Link: 26943776

Variant Present in the following documents:

• Main text
• oncotarget-07-25064.pdf

View BVdb publication page